Atlas Trials

Evaluating Inflammatory and Immunological Changes of HIV-positive Patients Switching to DTG Dual Regimen Compared to Those Switching to a Triple Drugs Regimen (B/F/TAF)

Clinical trial NCT04054089 · COMPLETED

Trial details

NCT number
NCT04054089
Sponsor
Cristina Mussini
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HIV Infections
Start date
2020-01-23
Primary completion
2020-01-23
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.